HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cynthia Carter Selected Research

Neoplasms (Cancer)

9/2005Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cynthia Carter Research Topics

Disease

1Pathologic Complete Response
09/2005
1Breast Neoplasms (Breast Cancer)
09/2005
1Neoplasms (Cancer)
09/2005

Drug/Important Bio-Agent (IBA)

1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2005
1Fluorouracil (Carac)FDA LinkGeneric
09/2005
1Paclitaxel (Taxol)FDA LinkGeneric
09/2005

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2005